Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Csp (CSPI) Current Deferred Revenue (2016 - 2025)

Csp's Current Deferred Revenue history spans 16 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 37.68% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, down 37.68%, while the annual FY2025 figure was $1.5 million, 30.77% down from the prior year.
  • Current Deferred Revenue reached $1.6 million in Q4 2025 per CSPI's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $4.7 million in Q2 2022 to a low of $1.3 million in Q4 2023.
  • Average Current Deferred Revenue over 5 years is $2.4 million, with a median of $2.0 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 222.89% in 2022, then plummeted 66.83% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $2.2 million in 2021, then soared by 70.05% to $3.8 million in 2022, then tumbled by 66.83% to $1.3 million in 2023, then skyrocketed by 109.03% to $2.6 million in 2024, then plummeted by 37.68% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for CSPI's Current Deferred Revenue are $1.6 million (Q4 2025), $1.5 million (Q3 2025), and $1.6 million (Q2 2025).